Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone and misoprostol for termination of pregnancy at 64–140 days since LMP
2013-004294-27Phase 3Active
- Sponsor
- Concept Foundation
- Start
- Oct 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mifepristone + misoprostol in abortion (2 arms), sponsored by Concept Foundation. Primary endpoint: Rate of complete abortion. Started Oct 2013; status: active.
02
Drugs
mifepristone + misoprostol
03
Conditions
abortion
Beyond the preview
Go deeper on 2013-004294-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004294-27.